Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogens in the respiratory tract refer to a broad spectrum of infectious agents, including viruses, bacteria, and fungi, that invade the upper and lower respiratory systems (NIH, 2023). Common examples include Streptococcus pneumoniae, Influenza viruses, and Mycobacterium tuberculosis, which are primary drivers of global morbidity and mortality (WHO, 2022). These pathogens utilize various virulence factors to adhere to respiratory epithelium, evade the host immune response, and cause tissue damage leading to diseases like pneumonia and bronchitis (StatPearls, 2023). Because this term describes a diverse group of organisms rather than a single molecule, it does not represent a specific therapeutic target; instead, each pathogen contains unique molecular targets such as enzymes or structural proteins. Therapeutic intervention involves the use of antibiotics, antivirals, or antifungals designed to selectively inhibit microbial processes while minimizing harm to the host. The clinical management of these pathogens is increasingly complicated by the rise of multi-drug resistant strains, necessitating the development of novel anti-infective agents and vaccines (CDC, 2023). Effective treatment often requires rapid diagnostic identification to tailor therapy to the specific causative agent.
Drugs targeting these pathogens act through diverse mechanisms including the inhibition of bacterial cell wall synthesis, interference with viral entry or replication, and disruption of fungal cell membrane integrity (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogens in the respiratory tract.